Published: April 19, 2018

Introduction {#sec1}
============

Adult stem cells exhibit the ability to replace damaged and aged cells during normal epithelium regeneration as well as in response to injury and cellular stress, thereby maintaining tissue homeostasis. The mammalian adult gut epithelium contains intestinal stem cells (ISCs), which are located in crypts along the small intestine where they frequently proliferate to retain homeostatic status ([@bib5]). Proper ISC activities play a pivotal role in the maintenance of cellular homeostasis in the intestine. Dysfunctional ISC proliferation and/or differentiation in the gut epithelium are associated with chronic diseases and developmental abnormalities, such as inflammatory bowel diseases, dysplasia, and metaplasia ([@bib29]). However, the mechanisms that maintain gut homeostasis are still largely unknown. The *Drosophila* midgut shares many similarities with the mammalian small intestine in terms of organ structure and function. Genetic manipulation of evolutionarily conserved signaling pathways linked to ISC proliferation and differentiation in the *Drosophila* midgut has become a favorable model for investigations of ISC activities and the underlying mechanisms controlling epithelial regeneration and homeostasis ([@bib2], [@bib7], [@bib31]).

*Drosophila* ISCs are derived from adult midgut precursors during larval stages, and thereafter reside in the midgut basal epithelium ([@bib34], [@bib35]). The ISC lineage is controlled by bidirectional Notch signaling in the daughter cells. A daughter cell with a high level of Notch activity becomes an intermediate enteroblast (EB), which further differentiates into an enterocyte (EC). Low degree of Notch activity results in retained ISC identity and, in combination with strong *Delta* and *Prospero* expression*,* the daughter cell is primed to differentiate into a pre-enteroendocrine (pre-EE) cell and further into an enteroendocrine (EE) cell ([@bib11], [@bib20], [@bib39], [@bib40], [@bib43], [@bib52]). Establishment and maintenance of the *Drosophila* gut epithelium require strict control of ISC proliferation and differentiation, and has to be balanced with cell death and delamination of differentiated ECs over time. Disruption of this cellular homeostasis can cause abnormal gut functionalities, such as tumor growth or increased susceptibility to infection ([@bib1], [@bib14], [@bib40], [@bib42]). Both intrinsic and extrinsic signals contribute to maintain normal ISC activities via several evolutionarily conserved signal transduction pathways, such as Notch/Delta, Janus kinase/signal transducer and activator of transcription, Jun N-terminal kinase, epidermal growth factor receptor, bone morphogenetic proteins, Hippo, Slit/Robo, and their downstream transcription factors ([@bib4], [@bib10], [@bib11], [@bib13], [@bib18], [@bib22], [@bib25], [@bib40], [@bib44], [@bib49]). Although these studies have endorsed a much better understanding of the processes that promote ISC proliferation, we still have rather limited knowledge about the mechanisms underlying the cellular homeostasis and how ISCs are maintained over a long period of time.

The *nubbin (nub)/POU domain protein 1 (Pdm1)* gene is a member of the class II POU transcription factor family and shares homology with the OCT1/POU2F1 and OCT2/POU2F2 proteins in mammals ([@bib21], [@bib48]). The *nub* gene is also evolutionarily related to the class V POU factor OCT4/POU5F1, which maintains stemness of embryonic stem cells (ESCs) ([@bib38]), and is one of the crucial pluripotency factors used for reprogramming of differentiated cells to induced pluripotent stem cells (iPSCs) ([@bib47]). Alternative transcripts have earlier been reported to be expressed from the *nub* gene ([@bib36]), and annotation of the *Drosophila* genome suggested at least two independent transcripts termed *nub-RB* and *nub-RD* (FlyBase: [FBgn0085424](flybase:FBgn0085424){#intref0010}). Recent experimental evidence has revealed that two protein isoforms, Nub-PB and Nub-PD, are expressed in *Drosophila* ([@bib16], [@bib30]). Transcription of the *nub* gene initiates at two major promoters that are separated by more than 30 kB. The two transcripts *nub-RB* and *nub-RD* are translated into a large (Nub-PB; 103.9 kDa) and a small (Nub-PD; 65.2 kDa) isoform, respectively, with a common C-terminal part comprising the POU-specific (POU~S~) and POU homeo (POU~H~) DNA binding domains ([Figures 1](#fig1){ref-type="fig"}A and 1B).Figure 1Midgut Length in Different *nub* Mutants during Adult Stages(A) Schematic structure of the *Drosophila nub* gene. The *nub* gene contains seven exons, as depicted with boxes, and transcription is initiated at two separate promoters (arrows). Exons and introns (solid black line) are drawn to scale, except for the large intron between exon 2 and 3 (dashed line), which is reduced in size.(B) Organization of Nub-PB and Nub-PD proteins encoded by the *nub* gene. Note that Nub-PB protein contains three unique exons (1, 2, and 3) while Nub-PD protein contains one unique exon (4). The shared three exons (5, 6, and 7) contain the coding sequence for the DNA-binding POU~S~ and POU~H~ domains (orange). Filled black triangle indicates the *nub-RB gal4* insertion site and black bold line shows the position of the *nub-RD-gal4* enhancer line. Two *nub* mutants, *nub*^*1*^; 412 transposable element insertion site indicated by a dashed triangle in (A) and *nub*^*E37*^ (an EMS-induced null mutant for both Nub-PB and Nub-PD; [@bib51]) are used in this work.(C) Midguts from 21-day-old control (top), *nub*^*1*^*/nub*^*1*^ (middle), and *nub*^*1*^*/+*; *nub*^*E37*^ (bottom) flies.(D) Measurement of midgut lengths in 5-day-old (circle) and 21-day-old (triangle) flies. Statistical significance was calculated using two-way ANOVA, Tukey\'s multiple comparisons test, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001. n = 13--21 guts. Error bars represent SEM.

We recently reported that Nub-PD is a transcriptional repressor of immune and stress response genes in the gut ([@bib16]), and that loss of such repression leads to gut bacterial dysbiosis and short life span ([@bib17]). Nub/Pdm1 immunostaining is robust in mature midgut ECs ([@bib6], [@bib28], [@bib33]), and it was suggested that Nub-PD acts as a differentiation factor by repressing *escargot* (*esg*) expression ([@bib25]). However, neither has a possible role of Nub-PB in regulation of intestinal stem cell activity been investigated, nor have the discrete roles and possible interplay between Nub-PB and Nub-PD in gut epithelium regeneration been analyzed.

Here, we report that Nub proteins are not only expressed in adult midgut ECs, but also present in progenitor cells (ISC + EB), and are necessary for maintaining cellular homeostasis during normal gut epithelium regeneration. Most importantly, we show that the two transcription factor isoforms, Nub-PB and Nub-PD, play opposite roles in regulating ISC maintenance and proliferation in the posterior midgut. Loss of Nub-PB leads to hyperplasia, as progenitor cells fail to differentiate and instead continue to proliferate. In contrast, Nub-PD mutant clones fail to proliferate, indicating that Nub-PD is necessary for the maintenance of ISCs. We suggest that this represents a mechanism to regulate adult stem cell activity with two transcription factor isoforms acting in opposite manners, one as a differentiation factor, the other as a stemness factor.

Results {#sec2}
=======

Loss of Nub-PD Restricts Midgut Length during Adult Life {#sec2.1}
--------------------------------------------------------

To investigate whether *nub* is involved in regulation of adult gut homeostasis, the adult midgut length was measured in two different *nub* mutant fly strains, *nub*^*1*^ and *nub*^*E37*^. The *nub*^*1*^ mutation eliminates expression of the Nub-PD isoform, while neither isoform is produced in *nub*^*E37*^ ([@bib36], [@bib51]). Dissected midguts of 21-day-old *nub*^*1*^ flies were clearly shorter than midguts of control flies ([Figures 1](#fig1){ref-type="fig"}C and 1D), indicating that Nub-PD is involved in development or regeneration of the adult midgut. To distinguish between defects during larval/pupal development from regeneration failure in adults, the midgut length was measured in young flies (5 days after eclosion). As expected, midguts derived from controls were shorter at day 5 compared with day 21 ([Figure 1](#fig1){ref-type="fig"}D), demonstrating that the midgut length normally increases between days 5 and 21. However, the midgut length of *nub*^*1*^ flies did not increase with age ([Figure 1](#fig1){ref-type="fig"}D). This indicates that the short midguts of *nub*^*1*^ flies at day 21 are not caused by early developmental effects, but rather due to failure in maintaining cellular homeostasis in the midgut. The *nub*^*E37*^ mutant is lethal during the pupal stage, while heteroallelic *nub*^*1*^*/nub*^*E37*^ flies are viable. We used this combination to analyze whether Nub-PB is also involved in regulation of midgut length. Interestingly, loss of one copy of Nub-PB in the Nub-PD mutant background partly restored the midgut length at day 21 ([Figure 1](#fig1){ref-type="fig"}D), indicating that Nub-PB and Nub-PD may confer opposite roles in maintenance of midgut epithelial regeneration. Taken together, the changes in adult midgut length of different *nub* mutants suggest that both Nub isoforms are contributing to cellular homeostasis in the adult midgut.

Nub Is Expressed in Adult Midgut and in Cell Lines {#sec2.2}
--------------------------------------------------

Adult midgut ECs are recognized as large cells with polyploid nuclei, expressing *MyoIA* and marked by Nub antibody staining ([@bib6], [@bib22], [@bib28], [@bib33]). To reveal the specific expression of *nub-RB* and *nub-RD* transcripts, spatial expression of promoter-specific *nub-RB* and *nub-RD* reporter lines were analyzed. For analysis of *nub-RB* expression, a *MiMIC-*transgene (*nub*^*MI05126*^) ([@bib50]) ([Figure 1](#fig1){ref-type="fig"}A) was converted into a Gal4-expressing reporter and combined with *UAS-mCherry.* This reporter conferred robust staining throughout the adult midgut, overlapping with *MyoIA-lacZ-*positive ECs ([Figures 2](#fig2){ref-type="fig"}A--2A″ and [S1](#mmc1){ref-type="supplementary-material"}A--S1A″). For *nub-*RD expression, a number of Vienna tiles enhancer lines ([@bib26]) were analyzed and the *VT6452 Gal4* line, which carries a 2.2-kB fragment including part of the first *nub-RD* exon and downstream intron sequences ([Figure 1](#fig1){ref-type="fig"}A), revealed strong reporter gene expression in adult midgut ([Figures 2](#fig2){ref-type="fig"}B--2B″ and [S1](#mmc1){ref-type="supplementary-material"}B--S1B″). This demonstrates that both Nub-PB and Nub-PD are expressed in anterior and posterior midgut ECs. In addition, some cells with *nub-RB-* and *nub-RD*-driven mCherry expression were found to overlap with EBs, marked by the Notch activity reporter *GBE-Su(H)-*nlsGFP ([Figures 2](#fig2){ref-type="fig"}C--2D‴), indicating that Nub-PB and Nub-PD are also expressed in EBs. However, reporter lines are not optimal for following protein dynamics. Instead, immunostaining was used to analyze the cellular distribution of Nub, after first validating antibody specificity in *nub*^*E37*^ mutant clones ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2B‴). Interestingly, we observed Nub immunostaining in the nucleus of cells expressing *esg-gal4* driven GFP ([Figures 2](#fig2){ref-type="fig"}E--2E‴) and *esg-lacZ-*positive cells ([Figures 2](#fig2){ref-type="fig"}F--2F‴), indicating that Nub protein is expressed in progenitor cells. However, not all progenitor cells stained with Nub antibody and staining was not uniform throughout the nucleus, suggesting a dynamic nature of Nub proteins and post-translational modifications. Interestingly, mammalian OCT1/POU2F1 display a dynamic behavior, with regulated sub-nuclear localization and post-translational modifications in response to cellular stress, which was suggested to correlate with changes in transcriptional activity ([@bib12], [@bib24], [@bib32]). To increase the number of progenitor cells we aimed at analyzing midguts undergoing frequent regeneration. For this, oral infections were performed with *Erwinia carotovora carotovora 15* (*Ecc15*) to induce ISC proliferation ([@bib13]). Importantly, the number of Nub-positive *esg-lacZ*-marked cells ([Figures 2](#fig2){ref-type="fig"}G--2G‴) increased upon *Ecc15* infection, validating that Nub is expressed in progenitor cells during stimulated regenerative conditions. To further analyze Nub expression in dividing cells, we analyzed *Drosophila malignant blood neoplasm-2 (mbn-2)* cells in culture. Interestingly, Nub immunostaining was observed specifically in cells during mitosis. Although weak Nub immunostaining was evident throughout the cytosol of the dividing cells, it was highly concentrated at the midbody during anaphase ([Figure 2](#fig2){ref-type="fig"}H″), overlapping with microtubuli, marked by β-tubulin immunostaining ([Figures 2](#fig2){ref-type="fig"}H and 2H‴). For additional confirmation, we analyzed Nub immunostaining in the Fly-specific fluorescent ubiquitination-based cell-cycle indicator cell line, which enables specific labeling of different cell phases during the cell cycle ([@bib55]). Cells in G1 and S phases are labeled by GFP and RFP, respectively, while cells in G2/M phases express both GFP and RFP and thus appear yellow ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Nub antibody-stained cells ([Figure S1](#mmc1){ref-type="supplementary-material"}C‴) were expressing both GFP and RFP ([Figures S1](#mmc1){ref-type="supplementary-material"}C--S1C‴) markers, demonstrating that Nub protein was present in these cells during the G2/M phase. Taken together, antibody staining confirmed that Nub is expressed in actively dividing cells.Figure 2Localization of Nub in Adult Posterior Midgut and the mbn-2 Cell Line(A--D″) Midguts expressing *nub-RB \> mCherry* (A′--A″ and C′--C″; red) and *nub-RD \> mCherry* (B′--B″ and D′--D″; red), combined with EC-specific reporter (A, A″ and B, B″; green) or an EB-specific Notch reporter (C, C″ and D, D″; green) in 5-day-old female posterior midguts. White arrows indicate cells positive for both GBE reporter (C--D″) and *nub-RB* reporter (C--C″) or *nub-RD* reporter (D--D″).(E--F″) Nub antibody staining (E′, E″ and F′, F″; red) in 5-day-old female midguts with progenitor cells marked with *esg*^*ts*^*\> GFP* (E, E″; green) and *esg-lacZ* (F, F″; green). White arrows indicate cells positive for both Nub and *esg*-reporters.(G--G″) Nub antibody staining (G′--G″; red) in 5-day-old *esg-lacZ* (green) female midguts upon *Ecc15* infection for 12 hr. Note the increased number of Nub/*esg-*positive cells (white arrows) after infection.(H--H″) Immunostaining of *Drosophila* mbn-2 cells undergoing mitosis and cytokinesis using antibodies to Nub (H′--H″; red) and β-tubulin (H and H″; green). White arrows show Nub staining in the midbody structure during cytokinesis.Scale bars, 20 μm in (A)--(G″) and 10 μm in (H)--(H″).See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Loss of Nub-PB in Progenitor Cells Leads to Increased *esg* Expression and ISC Proliferation {#sec2.3}
--------------------------------------------------------------------------------------------

Next, we aimed at characterizing the roles of the two Nub protein isoforms in the regulation of ISC activity and differentiation. While Nub-PD has been shown to confer proliferation in embryonic neuroblasts ([@bib3]), nothing is known about the function of Nub-PB. We used an RNAi line directed specifically against *nub-RB* in combination with the *esg*^*ts*^ *flip-out (F/O)* system ([@bib22]) to analyze whether Nub-PB is involved in turnover of posterior midgut epithelial cells. In midguts of control flies, *esg-*gal4 drives UAS-GFP expression in progenitor cells (ISC + EB) and, upon flip-out, small clusters of daughter cells were labeled by *actin-*gal4-driven GFP ([Figure 3](#fig3){ref-type="fig"}A). Overexpression of *nub-RB* for 7 days eliminated all GFP-marked cells ([Figure 3](#fig3){ref-type="fig"}B), indicating that no new progenitor cells were generated. In contrast, depletion of *nub-RB* promoted the growth of hyperplastic masses of GFP-positive cells ([Figure 3](#fig3){ref-type="fig"}C), indicating increased ISC proliferation and rapid epithelial turnover. To confirm this, we compared the number of mitotic cells by phospho-histone 3 (PH3) labeling following overexpression or downregulation of *nub-RB* in progenitor cells. The number of PH3-positive cells was significantly decreased upon *nub-RB* overexpression ([Figures 3](#fig3){ref-type="fig"}E and 3H) compared with control ([Figures 3](#fig3){ref-type="fig"}D and 3H). In contrast, *nub-RB* downregulation resulted in hyper-proliferation ([Figures 3](#fig3){ref-type="fig"}F and 3H). These results indicate that the role of Nub-PB is to block proliferation and to drive differentiation in the midgut. Recently, Esg has been reported to act as a stemness factor in adult midgut, as reducing *esg* expression in stem cells decreased their proliferative capacity ([@bib25]). To examine whether *esg* is involved in *nub-RB* depletion-induced hyper-proliferation, we downregulated both *nub-RB* and *esg* in progenitor cells and measured the rate of ISC proliferation. Importantly, this abolished the hyper-proliferative phenotype ([Figures 3](#fig3){ref-type="fig"}G and 3H), suggesting that *esg* is required for *nub-RB* depletion-induced ISC hyper-proliferation. In addition, *nub-RB* overexpression caused a significant decrease in *esg* expression ([Figure 3](#fig3){ref-type="fig"}I), whereas *nub-RB* downregulation promoted increased *esg* transcript levels ([Figure 3](#fig3){ref-type="fig"}I). This suggests that Nub-PB inhibits ISC proliferation in newly formed daughter cells, by direct or indirect repression of *esg* expression, promoting them to the exit the cell cycle and begin differentiation.Figure 3Nub-PB Regulates ISC Proliferation by Repression of *esg* Expression in Progenitor Cells(A--C) Gut epithelial turnover experiments using *esg*^*ts*^*F/O* system in posterior midguts, control (A), after *nub-RB* overexpression (B) and *nub-RB* downregulation (C) for 7 days, respectively.(D--G) PH3 antibody staining (red) in 5-day-old control midguts (D), upon *nub-RB* overexpression (E), *nub-RB* downregulation (F), and co-downregulation of *nub-RB* and *esg* (G) in progenitor cells (ISC + EB, GFP-labeled) driven by *esg-gal4*. White arrows indicate PH3-positive cells. Scale bars, 20 μm in (A)--(G).(H) Quantification of PH3-positive cells in the region of interest (ROI) (approximately R5 region; [@bib15]) from control (filled circles, n = 14), *nub-RB* overexpression (filled rectangles, n = 10), *nub-RB* downregulation (filled triangles, n = 14), and co-downregulation of *nub-RB* and *esg* (filled quadrangles, n = 13) midguts. Statistical significance was calculated using unpaired t test, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.(I) Quantification of *esg* mRNA expression levels in guts dissected from control (filled circles, n = 3), *nub-RB* overexpression (filled rectangles, n = 3), and *nub-RB* downregulation (black triangles, n = 3) flies. Statistical significance was calculated using unpaired t test, ^∗^p \< 0.05, ^∗∗^p \< 0.01. Error bars in each graph represent SEM.

Nub-PB Functions in EBs to Regulate Differentiation {#sec2.4}
---------------------------------------------------

To clarify in which cell types Nub-PB normally acts to regulate proliferation and differentiation, we depleted *nub-RB* expression by RNAi either in ISCs (*esg*^*ts*^*;Su(H)GBE-Gal80*), in EBs (*Su(H)GBE-Gal80*^*ts*^) (hereafter referred to *esg*^*ts*^*;GBE-Gal80* and *GBE*^*ts*^, respectively), or in both (*esg*^*ts*^). Reduction of *nub-RB* expression in ISC + EB cells with *esg-Gal4* for 21 days led to pronounced accumulation of non-differentiated *esg-*positive GFP clusters in the anterior and posterior midgut ([Figures 4](#fig4){ref-type="fig"}A--4B‴ and [S3](#mmc1){ref-type="supplementary-material"}A--B″). This suggests that depletion of *nub-RB* in *esg*-positive cells is associated with loss of progenitor cell differentiation. This was confirmed by the absence of differentiated EE cells in the same region, using Prospero (Pros) antibody staining ([Figures 4](#fig4){ref-type="fig"}B--4B‴), indicating that both EC and EE lineage differentiation is defect. In the adult midgut, EBs are transient non-proliferative cells, which either differentiate rapidly after completing cell division and cytokinesis, or remain as EBs with the capacity to differentiate later ([@bib35], [@bib39]). To investigate the role of Nub-PB in EBs, *nub-RB* was downregulated specifically in EBs by using *GBE*^*ts*^. Strikingly, this also promoted strong accumulation of GFP-labeled cell clusters in the anterior and posterior midgut ([Figures 4](#fig4){ref-type="fig"}C--4D‴ and [S3](#mmc1){ref-type="supplementary-material"}C--S3D″). Furthermore, there were more PH3-positive cells in the anterior midgut after *nub-RB* downregulation in EBs ([Figures 4](#fig4){ref-type="fig"}C″--4D‴ and 4G), suggesting that EB-specific *nub-RB* depletion increases ISC proliferation. In contrast, we did not observe any changes in cell proliferation or differentiation upon *nub-RB* downregulation in ISCs ([Figures 4](#fig4){ref-type="fig"}E, 4F, 4H, and [S3](#mmc1){ref-type="supplementary-material"}E--S3F″), indicating that Nub-PB does not play a direct role in regulating stem cell activity. In summary, Nub-PB appears to specifically function in EBs to block proliferation and promote differentiation.Figure 4Nub-PB Functions in EBs to Control Differentiation(A--B‴) Prospero (Pros) antibody staining (red) in the anterior midgut of control (A′--A‴) and after *nub-RB* downregulation (B′--B‴) in progenitor cells (ISC + EB, GFP-labeled) for 21 days.(C--D‴) PH3 antibody staining (red) in the anterior midgut of control (C′--C‴), and after *nub-RB* downregulation (D′ and D‴) in EBs (GFP-labeled) for 21 days. Note that more mitotic cells are present upon *nub-RB* downregulation, white arrows in (D′--D‴).(E and F) Downregulation of *nub-RB* specifically in ISCs (GFP-labeled) using *esg*^*ts*^*;GBE-Gal80* in anterior midgut for 21 days. Scale bars, 20 μm in (A)--(F).(G) Quantification of PH3-positive mitotic cells in the R2 region from control guts (C‴) (n = 10) and *nub-RB* downregulation guts (D‴) (n = 10).(H) Quantification of GFP-labeled stem cell numbers in the R2 region in control guts (E) (n = 5) and after *nub-RB* downregulation (F) (n = 6). Statistical significance was calculated using unpaired t test, ^∗∗^p \< 0.01. ns, not significant. Error bars in each graph represent SEM.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Overexpression of Nub-PB Rescues a Notch RNAi-Mediated Differentiation Defect {#sec2.5}
-----------------------------------------------------------------------------

Notch signaling is a core pathway for controlling ISC fate specification and its inhibition leads to both ISC and EE tumor formation in the posterior midgut ([@bib40]). As *nub-RB* RNAi in progenitor cells results in accumulation of non-differentiated progenitor-like cells, we next investigated whether Nub-PB is involved in Notch RNAi-mediated differentiation defects. As expected, downregulation of Notch in progenitor cells for 2 or 5 days resulted in both ISC and Pros-positive EE tumor formation ([Figures 5](#fig5){ref-type="fig"}A, 5B, 5E, and 5F), confirming that Notch signaling is required for both ISC proliferation and differentiation ([@bib35], [@bib40]). Overexpression of *nub-RB* in progenitor cells for 2 days reduced the number of stem cells ([Figure 5](#fig5){ref-type="fig"}C) and erased almost all *esg*-positive GFP progenitor cells after 5 days ([Figure 5](#fig5){ref-type="fig"}G), approving that overexpression of *nub-RB* blocks stem cell proliferation ([Figure 3](#fig3){ref-type="fig"}). Importantly, downregulation of Notch did not cause ISC and EE tumor formation when combined with *nub-RB* overexpression for 2 or 5 days ([Figures 5](#fig5){ref-type="fig"}D and 5H), indicating that high expression levels of Nub-PB in progenitor cells rescues the Notch RNAi-mediated differentiation defect, including EE tumor formation. It has been shown that *esg* is required for Notch RNAi-induced tumor formation ([@bib25]), and our data suggest that overexpression of *nub-RB* repressed *esg* expression ([Figure 3](#fig3){ref-type="fig"}). Taken together, these results show that Nub-PB acts as a tumor suppressor in Notch RNAi background, possibly by repression of *esg* expression, either directly or indirectly.Figure 5Overexpression of *nub-RB* Blocks Notch RNAi-Driven Differentiation DefectsPros antibody staining (red) in 2-day-old (A--D) and 5-day-old (E--H) posterior midguts. Downregulation of *notch* in progenitor cells, driven by *esg*^*ts*^*,* led to both ISC + EB (green) and EE (red) tumor-like cell formation (B and F) in posterior midguts compared with controls (A and E). *nub-RB* overexpression combined with *notch* IR in progenitor cells inhibits tumor formation both in 2-day-old (D) and 5-day-old (H) posterior midguts. Scale bars, 20 μm.

Nub-PD Is Required for Both Basal and Infection-Induced ISC Proliferation and Regulates ISC Fate in an Opposite Manner Compared with Nub-PB {#sec2.6}
-------------------------------------------------------------------------------------------------------------------------------------------

To analyze the role of Nub-PD in regulation of ISC proliferation we measured the mitotic activity in midguts of the Nub-PD mutant *nub*^*1*^ by using PH3 antibody staining. The number of PH3-positive cells was significantly reduced in *nub*^*1*^ posterior midgut compared with control ([Figures 6](#fig6){ref-type="fig"}A--6C), indicating a low mitotic activity in Nub-PD mutant guts. Moreover, stem cell-specific Delta antibody staining confirmed reduced numbers of ISCs in *nub*^*1*^ midguts ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4C). It was also evident that *nub*^*1*^ midguts display aberrant epithelium cell arrangements, with no or weak Armadillo staining (a cell adhesion marker) in most ECs compared with control ([Figures S4](#mmc1){ref-type="supplementary-material"}D and S4E), suggesting defects in the regeneration process. However, the EE lineage was not changed in *nub*^*1*^ midguts, as the proportion of Pros-positive EE cells was comparable in control and *nub*^*1*^ midguts ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F). Next, we investigated the mitotic activity in *nub*^*1*^ midguts in response to *Ecc15* infection. As expected, fewer PH3-positive cells were found in *nub*^*1*^ uninfected posterior midguts compared with controls ([Figures 6](#fig6){ref-type="fig"}D, 6F, and 6H), confirming the low level of ISC proliferative rate in *nub*^1^ midguts. Importantly, *Ecc15* infection for 12 hr triggered ISC division both in control and *nub*^*1*^ posterior midgut ([Figures 6](#fig6){ref-type="fig"}E, 6G, and H), but the number of PH3^+^ cells in *nub*^*1*^-infected midguts was significantly lower compared with infected control midguts ([Figure 6](#fig6){ref-type="fig"}H), suggesting that Nub-PD is required for full activation of ISC proliferation upon *Ecc15* infection. Taken together, Nub-PD is necessary for accurate rate of ISC proliferation both in basal and infection-induced conditions.Figure 6Nub-PD Is Required for Both Basal and Infection-Induced ISC Proliferation and Regulates ISC Proliferation in an Opposite Manner Compared with Nub-PB(A and B) PH3 antibody staining (red) in 5-day-old control (A) and *nub*^*1*^ mutant (B).(C) Quantification of PH3-positive cells in the R5 region from control guts (A) (n = 10) and *nub*^*1*^ mutant guts (B) (n = 10). Statistical significance was calculated using unpaired t test, ^∗∗∗^p \< 0.001.(D--G) PH3 antibody staining (red) in 5-day-old control (*w+; FRT40A*) and *nub*^*1*^ mutant (*w+; nub*^*1*^*FRT40A*) after mock (D and F) and *Ecc15* (E and G) infection for 12 hr.(H) Quantification of PH3-positive cells in the R5 region, after *mock* and *Ecc15* infection (n = 7--9). Statistical significance was calculated using two-way ANOVA, Tukey\'s multiple comparisons test. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001.(I--K) Lineage tracing analysis using MARCM system in control (I), *nub*^*1*^ (J), and *nub*^*E37*^ mutant (K) posterior midguts (R5 region).(L) Quantification of the number of cells within each clone from control (I) (n = 142 clones), *nub*^*1*^ (J) (n = 91 clones), and *nub*^*E37*^ mutant (K) (n = 105 clones). Statistical significance was calculated using unpaired t test. ^∗∗∗∗^p \< 0.0001. Error bars in each graph represent SEM.Scale bars, 20 μm in (A), (B), (D)--(G), and (I)--(K). See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

To investigate the interplay between Nub-PB and Nub-PD during cell fate determination we used MARCM system to track mitotic cell fates during development ([@bib27]). MARCM was performed in Nub-PD mutant (*nub*^*1*^) and Nub-PB/Nub-PD mutant (*nub*^*E37*^) midguts to examine how Nub isoforms determine ISC fate. As shown in [Figure 6](#fig6){ref-type="fig"}, control clones ([Figure 6](#fig6){ref-type="fig"}I) became multicellular with an average number of 15--30 cells in each clone ([Figure 6](#fig6){ref-type="fig"}L), while *nub*^*1*^ clones ([Figure 6](#fig6){ref-type="fig"}J) were always single-cell clones, confirming that Nub-PD is required for ISC proliferation. Strikingly, the *nub*^*E37*^clones ([Figure 6](#fig6){ref-type="fig"}K), which lack both Nub-PD and Nub-PB, were multicellular and had similar cell numbers as the control ([Figure 6](#fig6){ref-type="fig"}L), indicating that, upon concomitant loss of both Nub-PB and Nub-PD, ISC proliferation is rescued. In addition, we observed many single-cell clones in the posterior midgut after overexpression of *nub-RB* both in controls ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5J) and in *nub*^*E37*^ background ([Figures S5](#mmc1){ref-type="supplementary-material"}E and S5J), suggesting that high levels of Nub-PB expression in progenitor cells indeed block ISC proliferation, which corroborates the results of [Figure 3](#fig3){ref-type="fig"}. Surprisingly, we did not observe any multicellular clones in the posterior midgut upon *nub-RD* overexpression in control background ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5J) or in combination with the *nub*^*E37*^ background ([Figures S5](#mmc1){ref-type="supplementary-material"}F and S5J), indicating that Nub-PD overexpression is not sufficient for activating ISC proliferation. Rather it blocked proliferation upon overexpression, a result that will be further discussed below.

The fact that the *nub^E37^* MARCM clones resembled control clones with normal proliferation rate was surprising, and we decided to investigate this further with an independent approach, using a *nub-RB/RD IR* line, in which both *nub-RB* and *nub-RD* are targeted for degradation. In contrast to the hyper-proliferation caused by *nub-RB IR* ([Figures S5](#mmc1){ref-type="supplementary-material"}G and S5H), expression of *nub-RB/RD IR* in progenitor cells rescued the hyper-proliferation ([Figure S5](#mmc1){ref-type="supplementary-material"}I), demonstrating that the hyper-proliferation is Nub-PD dependent, and that concomitant loss of Nub-PB and Nub-PD restores cellular homeostasis. Thus, these results strongly indicate that Nub-PB and Nub-PD regulate ISC fate in opposite direction and suggest that the primary role of Nub-PD is to inhibit Nub-PB-driven differentiation, thereby ensuring ISC maintenance.

Discussion {#sec3}
==========

In the past few years, Nub/Pdm1 has been used as a marker of mature ECs in the *Drosophila* midgut ([@bib6], [@bib28], [@bib33]), but a direct role in epithelium regeneration has not been fully investigated. Here, we found that Nub isoforms are not only highly expressed in differentiated ECs, but also present in progenitor cells in the midgut. Nub immunostaining was not evident in all progenitor cells but specifically observed during mitosis and in a subset of EBs. This may either reflect that Nub protein concentration is very dynamic during the cell cycle or that antibodies directed against Nub are unable to detect its antigen during other phases of the cell cycle due to post-translational modifications and/or protein-protein interactions and complex formations. In addition to these immunostaining results, several global RNA sequence datasets of sorted midgut cells, such as the Flygut-seq (<http://flygutseq.buchonlab.com/data>) and ([@bib53]) have indicated expression of the *nub* gene in ISCs and EBs.

The observation that Nub immunostaining is enriched in the midbody of dividing cells may reflect a role of Nub either during the mitosis itself or directly after, in early G1 phase. In mammalian cells, OCT1/POU2F1 is phosphorylated in early mitosis and then concentrated in the midbody during cytokinesis, and was suggested to take part in regulation of mitosis ([@bib23]). Importantly, both depletion and overexpression of OCT1/POU2F1 interfered with normal mitosis. Moreover, OCT4/POU5F1 is phosphorylated at the onset of mitosis and then dephosphorylated after exiting M phase. This cycle is necessary for its role in resetting the transcription machinery and to maintain ESC pluripotency ([@bib46]). It is therefore plausible that the presence of OCT/POU proteins in mitotic cells, their post-translational modifications, and their role as transcriptional regulators in early G1 phase is important for regulation of normal stem cell division and for re-entering another round of the cell cycle.

Mammalian Oct/Pou genes are also producing several isoforms, but knowledge about their specific roles is relatively limited ([@bib54]). However, it was recently reported that different isoforms made from the human Oct1/Pou2f1 gene control expression of distinct sets of genes ([@bib41]). Interestingly, these OCT1 isoforms are produced from transcripts initiated at independent transcriptional start sites, giving rise to three OCT1 isoforms with different N termini but identical DNA-binding domains, resembling how the *nub* gene is organized. The genes for Oct2/Pou2f1 and Oct4/Pou2f11 also produce several isoforms via alternative splicing. These different isoforms have been suggested to regulate neural differentiation, pluripotency, and some have been linked to malignancy ([@bib54]).

Here, we show that *Drosophila* Nub isoforms are involved both in the maintenance of the stemness of ISCs and in the differentiation of the EB to EC lineage. The role of Nub-PD as a stemness factor was demonstrated by the loss of ISC proliferation in whole midguts and in MARCM clones ([Figure 6](#fig6){ref-type="fig"}). However, overexpression of *nub-RD* did not activate cell division in the MARCM clones ([Figure S5](#mmc1){ref-type="supplementary-material"}), but rather promoted differentiation. This result corroborates the findings of [@bib25], who reported that overexpression of Nub-PD in gut progenitor cells forced differentiation into ECs. One possibility is that the concentration of Nub-PD in ISCs is critical, and that overloading the cell with Nub-PD causes cell-cycle exit and differentiation. Importantly, the dosage of OCT4 is critical for maintaining stem cell self-renewal of ESCs, and both up- and downregulation of OCT4 induce differentiation into alternative lineages ([@bib38]). Similarly, accurate concentration of OCT1 was critical for normal mitotic progression ([@bib23]). In the *Drosophila* embryonic nervous system, misexpression of Nub-PD results in neuroblast proliferation ([@bib3], [@bib8], [@bib9]). It is therefore evident that Nub-PD has the capacity to stimulate neurogenic stem cells to proliferate.

A recent paper reported that one of the Snail family transcription factors, Esg, could directly bind to the promoter region of the *nub* gene and repress its expression, and it was suggested that such repression is necessary to maintain ISC identity ([@bib25]). However, the study did not consider the two isoforms encoded by the *nub* gene and only focused on Nub-PD. Furthermore, it was suggested that Esg and Nub might have bidirectional regulatory roles in progenitor cells in different conditions ([@bib25]). Here we show that overexpression of *nub-RB* in progenitor cells blocks ISC proliferation, possibly by downregulation of *esg* expression, either directly or indirectly. In correlation with this, downregulation of *nub-RB* by RNAi in progenitor cells elevated the expression level of *esg* and activation of ISC proliferation ([Figure 3](#fig3){ref-type="fig"}). Moreover, the hyper-proliferation phenotype induced by *nub-RB* RNAi was abolished when *esg* was depleted simultaneously. It is therefore likely that Nub-PB is controlling *esg* expression in progenitor cells, thereby prohibiting ISC proliferation. Moreover, *nub-RB* RNAi results indicate that Nub-PB is normally repressing proliferation in EBs. As a consequence, the increase in PH3 labeling upon EB-specific *nub-RB* RNAi is most likely a result of both ISC daughter cells maintaining self-renewal capacity in the absence of Nub-PB and sustained *esg* expression.

We propose a model for of how Nub-PB and Nub-PD may regulate ISC proliferation and differentiation ([Figure 7](#fig7){ref-type="fig"}). In this model, Nub-PB acts as a repressor of *esg* expression in progenitor cells, promoting differentiation of one of the daughter cells to an EB. Nub-PD, which counteracts the activity of Nub-PB, will thereby inhibit differentiation and allow stem cells to continue to divide, i.e., to maintain stemness. In the absence of Nub-PD (*nub*^*1*^ mutant clones), Nub-PB will push both daughter cells to exit the cell cycle and promote rapid differentiation, hence, the stem cells will be lost and no more cell divisions will occur. In contrast, depletion of Nub-PB (*nub-RB* IR) will lead to a continuously high level of *esg* expression and enable both daughter cells to continue to divide, promoting increased number of ISCs. In this model, the primary role of Nub-PD is to repress the activity of Nub-PB on its target genes, meaning that midguts lacking both Nub-PB and Nub-PD would have a relatively normal cell cycle and rate of proliferation, which was the case in the *nub*^*E37*^ null mutant, as well as upon *nub-RB/RD* RNAi in progenitor cells. This may imply that the *nub* gene itself is dispensable for ISC proliferation during basal conditions. However, the *Drosophila pdm2* gene, which is a *nub* paralog, has been shown to confer a redundant role during neuroblast cell proliferation and specification in the embryo ([@bib9]). It is, therefore, possible that Pdm2 can compensate for the loss of *nub* and maintain normal ISC proliferation rate. In contrast, unbalanced expression of the two Nub protein isoforms, either as a result of overexpression or RNAi, interfered with cell proliferation in all variants tested. Thus, well-tuned expression of the two Nub protein isoforms is necessary for normal ISC proliferation and differentiation. Moreover, it was recently reported that Nub-PB and Nub-PD regulate the expression of immune genes in gut ECs in an antagonistic manner ([@bib30]), pointing to the possibility that Nub-PB and Nub-PD play important roles in controlling epithelial renewal in the gut upon infection. This is supported by the fact that in *nub*^*1*^ mutants, ISC proliferation was considerably reduced ([Figures 6](#fig6){ref-type="fig"}A--6H), suggesting that Nub-PD is also required for infection-induced stem cell division.Figure 7Proposed Model for *nub* Gene Regulation of ISC Proliferation and DifferentiationIn wild-type condition, Nub-PB and Nub-PD are highly expressed in differentiated ECs. In addition, Nub-PB and Nub-PD are transiently expressed in progenitor cells. The present results indicate that Nub-PB specifically functions in EBs to block ISC proliferation and to promote differentiation toward EC fate. The mechanism for Nub-PB-driven proliferation inhibition is suggested to involve repression of Esg function, which is required for ISC proliferation. In the proposed model, Nub-PB activity is repressed by Nub-PD, allowing *esg* expression, stem cell maintenance and division. In *nub*^*1*^ mutants, ISC proliferation is, however, severely compromised due to the loss of Nub-PD, and therefore Nub-PB will drive rapid EB differentiation to Nub-PB-positive ECs. In contrast, downregulation of *nub-RB* in progenitor cells will trigger ISC proliferation by increasing the expression level of *esg*, and the loss of Nub-PB will also inhibit differentiation of EBs to ECs. In *nub*^*E37*^ mutant clones, ISCs display normal proliferation and differentiation rate possibly due to compensation by other unknown factors. Filled gray circles indicate nuclei and dashed gray lines or text indicate weak activity or expression.

In a recent study, [@bib45] found that mammalian POU2F1/OCT1 and POU5F1/OCT4 occupy both overlapping and independent sets of target genes in ESCs and their daughters. Importantly, concomitant with the loss of OCT4 binding, OCT1 occupancy increased during differentiation ([@bib45]). This implies that POU/OCT factors may act in succession to regulate developmental processes based on sequential binding to common targets. Phylogenetic analyses have indicated that *Drosophila* and other invertebrates lack POU5 factors, i.e., direct homologs of OCT4/POU5F1, while Nub is most closely related to mammalian OCT1/POUF1 and OCT2/POUF2 ([@bib19]). Importantly, though, it was shown using high-throughput SELEX experiments that the DNA binding specificity is highly conserved between mouse/human OCT4, OCT1, and *Drosophila* Nub ([@bib37]). This suggests that Nub proteins are in fact functionally related to both OCT4 and OCT1 in terms of DNA binding specificity. We speculate that Nub-PD shares functional analogy with OCT4 and OCT1 in sustaining stem cell renewal capacity, and thereby also restoring multipotency (OCT4 and Nub-PD), and that Nub-PB acts analogous to OCT1 in supporting differentiation of specific cell lineages. It is well established that mammalian POU/OCT factors act as crucial regulators of stemness, multipotency, and differentiation. This work suggests that these properties of POU/OCT factors are evolutionarily ancient, operating in organisms as divergent as *Drosophila* and mammals.

Experimental Procedures {#sec4}
=======================

Immunofluorescence Staining and Imaging {#sec4.1}
---------------------------------------

All crosses were set up at 18°C, then F1 progenies were kept at 18°C for 3--7 days before transferring to 29°C for initiation of GAL4 activity. Otherwise, flies were reared at 25°C.

Female intestines were dissected in PBS, pH 7.4 (PBS) and fixed in 4% paraformaldehyde for 1 hr at room temperature (RT), then briefly washed in PBST (PBS with 0.1% Triton X-100) and blocked with PBST+ 0.5% normal goat serum for 30 min at RT. The tissues were incubated with primary antibodies at 4°C overnight on a shaker. Next day, samples were washed in PBST (4 × 15 min) and incubated with secondary antibodies at RT for 2 hr on a shaker. Finally, samples were mounted in DABCO (Sigma) on a glass slide after staining with DAPI (Sigma). Images were taken by LSM 780 (Zeiss) or LSM 500 (Zeiss) and processed with Adobe Photoshop CS6 and Adobe Illustrator CS6.

RT-qPCR {#sec4.2}
-------

Total RNA was extracted from 20 to 30 adult females\' intestines with TRIzol (Bioline). cDNA synthesis and PCR were done as described previously ([@bib16]). TaqMan Gene Expression Assays (Applied Biosystems) were used to quantify the given gene expression (TaqMan probes: *esg*: Dm01841264_s1; Applied Biosystems); all experiments were analyzed in biological triplicates and the measured mRNA expression level were normalized relative to those of *RpL32*.

Statistical Analysis {#sec4.3}
--------------------

Statistical significances were calculated using either unpaired t test in pairwise comparisons or one- or two-way ANOVA combined with Tukey\'s *post hoc* test in multiple comparisons as shown in related figures. Graphical plotting was done in GraphPad Prism 6.0.
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